Oral valganciclovir as preemptive therapy for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

2024-02-082024-02-082014-12-06Özkocaman, V. vd. (2014). "Oral valganciclovir as preemptive therapy for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients". Blood, 124, Issue: 21.0006-49711528-0020https://hdl.handle.net/11452/39589eninfo:eu-repo/semantics/closedAccessOral valganciclovir as preemptive therapy for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipientsArticle000349242703190124Hematology